Semaglutide, COVID-19 Mortality, and the Power of Harnessing Ongoing Clinical Trials During Unexpected Outbreaks
- PMID: 39217571
- DOI: 10.1016/j.jacc.2024.08.035
Semaglutide, COVID-19 Mortality, and the Power of Harnessing Ongoing Clinical Trials During Unexpected Outbreaks
Keywords: COVID-19; clinical trials; semaglutide.
Conflict of interest statement
Funding Support and Author Disclosures The author has reported that he has no relationships relevant to the contents of this paper to disclose.
Publication types
LinkOut - more resources
Full Text Sources
